Pancreatic-adenocarcinoma is relatively uncommon, but has
been proven to be an unyielding adversity. Pancreatic-cancer accounts only ~3%
of all cancer diagnoses and is the fourth cause of death for cancer in USA.
These rates are similar in Italy, where pancreatic-cancer accounts only 3% of
all cancer diagnoses and is the fifth cause of death.
This equates to 7% of all cancer deaths with a total of
~10,000 lives lost to pancreatic-cancer in 2009.Exercise has demonstrated
efficacy for the management of treatment related side effects and for improving
quality of life (QOL) across common cancers such as breast and prostate-cancer.
However very little data exists exploring the potential
impact of exercise in pancreatic-cancer patients despite the need to
counteract commonly experience adverse effects including significant weight-loss,
cancerrelated fatigue, nausea, and psychological distress.
